$ARTH +12% on huge clinical study news out today!
Post# of 89153
Posted On: 10/31/2016 12:05:29 PM
$ARTH +12% on huge clinical study news out today!
Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients. Arch's flagship development stage product candidate, known as the AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in surgical procedures.
https://finance.yahoo.com/news/arch-therapeut...00428.html
Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients. Arch's flagship development stage product candidate, known as the AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in surgical procedures.
https://finance.yahoo.com/news/arch-therapeut...00428.html
(1)
(0)Scroll down for more posts ▼